Scarica l'app Stockscreener
0.00
100.00%
-76.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$76.01
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$16.97B
Reddito:
$4.13B
Utile/perdita netta:
$543.90M
Rapporto P/E:
0.00
EPS:
2.41
Flusso di cassa netto:
$957.20M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$76.07
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
0.00 | 16.97B | 4.13B | 543.90M | 957.20M | 2.41 |
ISRG
Intuitive Surgical Inc
|
457.79 | 165.27B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
149.04 | 42.53B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
44.42 | 37.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.87 | 36.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
213.81 | 31.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Downgrade | Argus | Buy → Hold |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Hologic Stock (US4364401012): Earnings Release Scheduled for Today - AD HOC NEWS
Blackstone & TPG Complete Hologic Acquisition, Appoint Joe Almeida as CEO - Digital Health News
The Official Home of the Women's Tennis Association | WTA Tennis - WTA Tennis
HPV Testing Market Size Expected to Reach $18.6 Billion at 11.2% - openPR.com
Is trending stock Hologic, Inc. (HOLX) a buy now? - MSN
Hologic, Inc. (HOLX) Stock Analysis: Steady Healthcare Innovator with Limited Upside Potential - DirectorsTalk Interviews
Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks - MSN
Blackstone, TPG said to be nearing over $17B deal for Hologic - MSN
Medicinal Microbiology Market Is Going to Boom | Major Giants bioMérieux SA, Hologic, Cepheid - openPR.com
HOLX (Hologic Inc.) posts 1.7 percent year-over-year revenue gain as Q1 2026 EPS misses consensus estimates.Crowd Trend Signals - Cổng thông tin điện tử Tỉnh Sơn La
Interventional Radiology Market is expected to Hit US$ 47.25 - openPR.com
New Evidence Backs Hologic’s AI-Powered Mammography Technology for Detecting Challenging Cancers - 01net
Hologic, Inc. (HOLX) Stock Analysis: Evaluating the Growth Potential in the Medical Instruments Sector - DirectorsTalk Interviews
[15-12G] HOLOGIC INC SEC Filing - Stock Titan
Lobbying Update: $390,000 of HOLOGIC INC. lobbying was just disclosed - Quiver Quantitative
HOLX SEC FilingsHologic Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Anatomic Pathology Market is Expected to Register a CAGR of 7.3% - openPR.com
Biopsy Devices Market Share & Growth: Hologic, Becton Dickinson, and Danaher Leading Precision Diagnostics - openPR.com
[EFFECT] HOLOGIC INC SEC Filing - Stock Titan
Hologic Stock 2026: Buy or Sell HOLX as Blackstone-TPG Buyout Nears Completion With $76 Cash Offer Plus CVR - International Business Times Australia
Sentiment Review: Is Hologic Inc vulnerable to short sellers2026 Catalysts & Safe Entry Trade Signal Reports - baoquankhu1.vn
Hologic: $18.3 Billion Take-Private Deal Completed As Women’s Health MedTech Company Goes Private - Pulse 2.0
Blackstone and TPG Complete Acquisition of Hologic; Names New CEO - MedTech Intelligence
Hologic (HOLX) executive equity awards cancelled and cashed out in merger - Stock Titan
Hologic (HOLX) president exits stock in $76 cash-and-CVR merger - Stock Titan
Merger leaves Hologic (HOLX) executive without any common shares - Stock Titan
Hologic (HOLX) CFO has equity awards cashed out in Hopper merger - Stock Titan
Hologic (HOLX) COO exits equity as merger pays $76 plus CVR per share - Stock Titan
Hologic (HOLX) counsel’s shares converted to $76 cash plus CVR in merger - Stock Titan
Hologic (HOLX) executive equity converted to $76 cash plus CVR in merger - Stock Titan
Hologic (HOLX) SVP stock converted at $76 plus CVR in merger - Stock Titan
Merger cashes out Hologic (HOLX) director Amy McBride’s equity awards - Stock Titan
Hologic (HOLX) director exits equity as merger pays $76 cash plus CVR - Stock Titan
Hologic (HOLX) director exits position as merger pays $76 plus CVRs - Stock Titan
Hologic (HOLX) director surrenders options and shares in cash-and-CVR merger - Stock Titan
Hologic (HOLX) director exits stake as Hopper merger pays cash and CVRs - Stock Titan
Hologic (NASDAQ: HOLX) director equity cashed out in merger - Stock Titan
Hologic (HOLX) CEO exits all company stock as $76 per share buyout closes - Stock Titan
Merger cashes out Hologic (HOLX) director Hantson’s stock and options - Stock Titan
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.76%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):